🇺🇸 FDA
Patent

US 11344577

Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

granted A61KA61K40/11A61K40/31

Quick answer

US patent 11344577 (Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA) held by The Board of Regents of the University of Texas System expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/32, A61K40/421